Paasa Logo
Actinium Pharmaceuticals, Inc. logo
ATNMAMEXMarket closedOpens 9:30am ET

Actinium Pharmaceuticals, Inc.

$1.14Last updated
-$0.04 (3.39%)Past day
Timezone

Actinium Pharmaceuticals, Inc. (AMEX: ATNM) is trading at $1.14, about ₹110 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 3.39% today. Indian residents can buy Actinium Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$1.16
Previous close:$1.18
Volume:62.02K

Today's low

$1.14

Today's high

$1.17

52 week low

$0.74

52 week high

$1.74

ATNM opened at $1.16, closed previously at $1.18, and has traded between $0.74 and $1.74 over the past 52 weeks.

About

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing and commercializing treatments, primarily focusing on those for bone marrow transplant (BMT) or other cellular and adoptive cell therapies. Its leading drug candidate, I-131 apamistamab (known as Iomab-B), is currently in a crucial Phase III clinical trial for its role in conditioning elderly patients with relapsed or refractory acute myeloid leukemia prior to BMT. Additionally, Iomab-B is being evaluated in a Phase I study for its use with CD19-targeted CAR T-cell therapy, a partnership with Memorial Sloan Kettering Cancer Center. The company's pipeline also includes several clinical and preclinical development programs that harness various isotopes such as Actinium-225, Iodine-131, and Lutetium-177. These programs are designed to target a range of validated cancer markers, including CD45, CD33, CD38, CD47, HER2, and HER3. Their applications span targeted conditioning regimens for cell and gene therapies, such as bone marrow transplantation, and as standalone or combination cancer therapeutics. Actinium has established strategic alliances, including a collaboration with Astellas Pharma, Inc. to create theranostics for solid tumor indications. Another partnership is with EpicentRx, Inc., concentrating on an innovative CD47 immunotherapy delivered via targeted radiotherapy. Furthermore, the company is working with AVEO Oncology on developing a HER3-targeting Antibody-Radio Conjugate (ARC) for solid tumors. Incorporated in 2000, Actinium Pharmaceuticals, Inc. is headquartered in New York, New York.

Country
US
CEO
Sandesh C. Seth
Exchange listed on
AMEX
Industry
Biotechnology
Base currency
USD
Full Time Employees
27
Sector
Healthcare
IPO date
27/12/2012

Key statistics

Avg. volume

79.76K

Market cap

$35.77M

P/E Ratio

3.17

Price-to-sales ratio

1.02

Enterprise value

-$3.88M

Free cash flow yield

-58.18%

Debt-to-equity ratio

0.04

Return on equity

-432.56%

ROIC

-81.40%

Beta

0.02

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$90.00K

Earnings per share

-$1.09

Free cash flow

-$24.68M

Net profit margin

32.23%

Gross margin

101.13%

EBITDA

-$33.07M

Revenue growth

0.00%

Similar securities

This is not an investment recommendation

How to buy Actinium Pharmaceuticals from India

Indian residents can buy Actinium Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Actinium Pharmaceuticals and place an order

    Find Actinium Pharmaceuticals by name or by its ticker, ATNM, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Actinium Pharmaceuticals trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Actinium Pharmaceuticals position in USD and INR. Actinium Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Actinium Pharmaceuticals from India

Trading and taxes when buying Actinium Pharmaceuticals from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneActinium Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Actinium Pharmaceuticals stock?

Yes. Actinium Pharmaceuticals (ATNM) has been listed on NYSE American since 2012, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Actinium Pharmaceuticals share cost in rupees?

One Actinium Pharmaceuticals share is $1.14 — about ₹110 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Actinium Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Actinium Pharmaceuticals from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Actinium Pharmaceuticals?

Yes. One Actinium Pharmaceuticals share is $1.14, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Actinium Pharmaceuticals.

How are gains on Actinium Pharmaceuticals shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Actinium Pharmaceuticals price. Paasa issues a capital-gains statement for your return.

Does Actinium Pharmaceuticals pay a dividend?

No. Actinium Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Actinium Pharmaceuticals from India?

NYSE American trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Actinium Pharmaceuticals shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Actinium Pharmaceuticals shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Actinium Pharmaceuticals holding, its cost and its closing value.

How do I sell Actinium Pharmaceuticals and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.